Molecular mechanisms underlying the synergistic interaction of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, with the multitargeted antifolate pemetrexed in non-small-cell lung cancer cells

1. Giovannetti, E.
2. Lemos, C.
3. Tekle, C.
4. Smid, K.
5. Nannizzi, S.
6. Rodriguez, J.A.
7. Ricciardi, S.
8. Danesi, R.
9. Giaccone, G.
10. Peters, G.J.